Cargando…
Adrenal βarrestin1 targeting for tobacco–associated cardiac dysfunction treatment: Aldosterone production as the mechanistic link
Tobacco kills 6 million people annually and its global health costs are continuously rising. The main addictive component of every tobacco product is nicotine. Among the mechanisms by which nicotine, and its major metabolite, cotinine, contribute to heart disease is the renin‐angiotensin‐aldosterone...
Autores principales: | Solesio, Maria E, Mitaishvili, Erna, Lymperopoulos, Anastasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581946/ https://www.ncbi.nlm.nih.gov/pubmed/31236278 http://dx.doi.org/10.1002/prp2.497 |
Ejemplares similares
-
Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison
por: Dabul, Samalia, et al.
Publicado: (2015) -
Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy
por: Lymperopoulos, Anastasios, et al.
Publicado: (2017) -
Nicotine-induced adrenal beta-arrestin1 upregulation mediates tobacco-related hyperaldosteronism leading to cardiac dysfunction
por: Cora, Natalie, et al.
Publicado: (2020) -
Structure–activity relationship study of angiotensin II analogs in terms of β‐arrestin‐dependent signaling to aldosterone production
por: Valero, Thairy Reyes, et al.
Publicado: (2016) -
βArrestins in Cardiac G Protein-Coupled Receptor Signaling and Function: Partners in Crime or “Good Cop, Bad Cop”?
por: Lymperopoulos, Anastasios, et al.
Publicado: (2013)